The use of retinoic acid for the treatment of endometriosis

Correspondence
  • 13 Downloads

Notes

Author contributions

FB: Project development, data collection, manuscript writing. SF: Manuscript writing/editing.

Compliance with ethical standards

Funding

This paper is not funded.

Conflict of interest

Fabio Barra declares that he has no conflict of interest. Simone Ferrero declares that he has no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

References

  1. 1.
    Lu H, Li S, Wu Q (2018) Retinoic acid regulates endometriotic stromal cell growth through upregulation of Beclin1. Arch Gynecol Obstet 297(1):93–99.  https://doi.org/10.1007/s00404-017-4549-8 CrossRefPubMedGoogle Scholar
  2. 2.
    Taylor RN, Kane MA, Sidell N (2015) Pathogenesis of endometriosis: roles of retinoids and inflammatory pathways. Semin Reprod Med 33(4):246–256.  https://doi.org/10.1055/s-0035-1554920 CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Hatice O, Abdullah B, Gökhan A, Remzi A, Ozlem Bozoklu A, Mehmet Ilkay K (2012) The efficacy of bevacizumab, sorafenib, and retinoic acid on rat endometriosis model. Reprod Sci 20(1):26–32.  https://doi.org/10.1177/1933719112452941 Google Scholar
  4. 4.
    Wieser F, Wu J, Shen Z, Taylor RN, Sidell N (2012) Retinoic acid suppresses growth of lesions, inhibits peritoneal cytokine secretion, and promotes macrophage differentiation in an immunocompetent mouse model of endometriosis. Fertil Steril 97(6):1430–1437.  https://doi.org/10.1016/j.fertnstert.2012.03.004 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Vercellini P, Vigano P, Somigliana E, Fedele L (2014) Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol 10(5):261–275.  https://doi.org/10.1038/nrendo.2013.255 CrossRefPubMedGoogle Scholar
  6. 6.
    Yamagata Y, Takaki E, Shinagawa M, Okada M, Jozaki K, Lee L, Sato S, Maekawa R, Taketani T, Asada H, Tamura H, Nakai A, Sugino N (2015) Retinoic acid has the potential to suppress endometriosis development. J Ovarian Res 8:49.  https://doi.org/10.1186/s13048-015-0179-6 CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Tafi E, Leone Roberti Maggiore U, Alessandri F, Bogliolo S, Gardella B, Vellone VG, Grillo F, Mastracci L, Ferrero S (2015) Advances in pharmacotherapy for treating endometriosis. Expert Opin Pharmacother 16(16):2465–2483.  https://doi.org/10.1517/14656566.2015.1085510 CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Academic Unit of Obstetrics and GynecologyOspedale Policlinico San MartinoGenoaItaly
  2. 2.Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI)University of GenoaGenoaItaly

Personalised recommendations